<DOC>
	<DOCNO>NCT01496638</DOCNO>
	<brief_summary>How coronary artery stenoses significant side branch stented ? A strategy stenting main vessel side branch compare strategy stenting main vessel stenting side branch necessary . The 2-stent strategy superior 1-stent strategy regard occurrence cardiac death , non-procedure related myocardial infarction re-revascularization percutaneous coronary intervention ( PCI ) coronary artery bypass grafting ( CABG ) .</brief_summary>
	<brief_title>The Nordic-Baltic Bifurcation Study IV</brief_title>
	<detailed_description>Design : - Randomised open multicentre trial . Patients : - Number 450 . Randomisation : - No side branch treatment group stenting main vessel side branch group . Evaluation endpoint : - Primary secondary endpoint assess independent endpoint committee . - The endpoint committee consist experience cardiologist professor Kristian Thygesen , Aarhus Universitetshospital , chairman . Sample size calculation : - A total 225 patient include group , total 450 patient . We expect primary endpoint rate 10 % ( cardiac death , non-procedure related myocardial infarction relate index lesion TLR 6 month ) 1- stent strategy group 3 % 2-stent strategy group . With alpha 5 % strength 80 % , 194 patient need group ( two-sided chi-square test ) demonstrate difference . The expected primary endpoint rate 6 month base 6 month MACE rate angiographic result previously publish study . In study , 6 month MACE rate 3.7 % find culotte group Nordic Stent Technique Study . Besides , angiographic restenosis rate 19.2 % 1-stent strategy group Nordic Bifurcation Study estimate translate MACE rate approximately 10 % present study . Analysis population : - The result analyze accord intention-to-treat principle . Data management : - The study report Datatilsynet ( The Danish Data Protection Agency ) agency 's guideline data management follow . Dedicated case record form ( CRF ) use faxed PCI research , Cardiac Cath . Lab. , Aarhus University Hospital , Skejby , DK-8200 Aarhus N , Denmark . Data store Access database double data entry use quality control . There log access attempt access . Back-up data original data cryptotized . Monitoring study : - The study monitor accord GCP rule independent professional . During study period , monitor regular contact participate department ensure trial conduct compliance protocol , GCP applicable regulatory requirement Publication : - Results , positive well negative , publish international cardiovascular journal . Publication author issue decide steer committee basis general involvement study ( draft protocol , core lab . function , end point committee membership , etc . ) number include patient .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Glucuronyl glucosamine glycan sulfate</mesh_term>
	<criteria>Stable unstable angina pectoris silent angina pectoris . Genuine bifurcation lesion ( Medina type 1,1,1 1,0,1 0,1,1 ) Lesion `` LAD/diagonal '' , `` Cx/obtuse marginal '' , `` RCAPDA/posterolateral branch '' `` LM/Cx/LAD '' . Diameter main vessel visual estimate &gt; 3.0 mm . Diameter side branch visual estimate &gt; 2.75 mm . Signed informed consent . STelevation infarction within 24 hour . Side branch lesion length &gt; 15 mm . Expected survival &lt; 1 year . Screatinine &gt; 200 Âµmol/l . Allergy Aspirin , Clopidogrel Ticlopidine . Allergy Sirolimus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>PCI</keyword>
	<keyword>Bifurcation lesion</keyword>
</DOC>